MeiraGTx Holdings (MGTX) EBT Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) posted EBT Margin of 21.09% for Q4 2025, up 100.18% on a QoQ basis from 11940.24% in Q3 2025, and up 17161.0% year-over-year from N/an in Q4 2024.
MeiraGTx Holdings (MGTX) EBT Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings' EBT Margin history runs 7 years deep, the most recent figure standing at 21.09% for Q4 2025.
- Quarterly EBT Margin rose 17161.0% year-over-year to 21.09% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 121.07% (up 40078.0% YoY) and the FY2025 annual result came in at 352.85%, up 57701.0% from the prior year.
- EBT Margin was 21.09% for Q4 2025 at MeiraGTx Holdings, up from 11940.24% in the prior quarter.
- Across five years, EBT Margin topped out at 831.24% in Q4 2022 and bottomed at 18101.77% in Q2 2024.
- A 5-year average of 2248.42% and a median of 503.35% in 2021 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin plunged 1721237 bps — and 2025, when it jumped 1697956 bps.
- MeiraGTx Holdings' EBT Margin stood at 20.32% in 2021, then surged by 4191 bps to 831.24% in 2022, then plunged by 61 bps to 321.03% in 2023, then slumped by 147 bps to 150.52% in 2024, then soared by 114 bps to 21.09% in 2025.
- Business Quant data shows MGTX's EBT Margin at 21.09% in Q4 2025, 11940.24% in Q3 2025, and 1122.22% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 21.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.09% |
| Sep 30, 2025 | -11,940.24% |
| Jun 30, 2025 | -1,122.22% |
| Dec 31, 2024 | -150.52% |
| Sep 30, 2024 | -380.37% |
| Jun 30, 2024 | -18,101.77% |
| Mar 31, 2024 | -7,019.37% |
| Dec 31, 2023 | 321.03% |
| Sep 30, 2023 | -698.02% |
| Jun 30, 2023 | -889.41% |
| Mar 31, 2023 | -1,028.04% |
| Dec 31, 2022 | 831.24% |
| Sep 30, 2022 | -506.89% |
| Jun 30, 2022 | -233.13% |
| Mar 31, 2022 | -534.14% |
| Dec 31, 2021 | -20.32% |
| Sep 30, 2021 | -341.87% |
| Jun 30, 2021 | -423.65% |
| Mar 31, 2021 | -503.35% |
| Dec 31, 2020 | -346.36% |